Pay in 4 interest-free payments of $6.05 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Biopsy-proven NASH : Patients with histologically confirmed NASH, particularly those with significant inflammation or early fibrosis (F1-F2), may be considered for off-label GLP-1 therapy, especially if they have failed lifestyle modification or have contraindications to other therapies like vitamin E or pioglitazone
PMID 22160702
Sugar, fat, ultra-processed foods, and alcohol engage overlapping gutbrain pathways
pAAV-hSyn-EGFP, plasmid from Addgene, 50465-AAV8, RRID: Addgene_50465-AAV8, virus packaged at UNC Vector Core (100 l at titre 7 10 12 vg ml 1 ), retroAAV2-EF1a-oNLS-oScarlet 52 (100 l at titre 3 10 13 vg ml 1 )), was delivered using a glass pipette at a flow rate of 50 nl per min driven by a microsyringe pump controller (World Precision Instruments, model Micro 4) per targeted site
US$ 27.96
US$ 25.88
US$ 22.74
US$ 25.56
US$ 20.44
